Anyone who suffered uterus perforation, vision loss or PTC while using a Mirena IUD is urged to visit DrugNews.net for more information or speak with a lawyer about their legal options.
New York, NY (PRWEB) August 08, 2014
The birth control safety center at DrugNews.net is alerting women using the Mirena IUD contraceptive of new research information on the site. A recent study found a higher incidence of breast cancer among women using the device*
DrugNews is a free resource for those using popular prescription drugs and medical devices. By giving patients the latest safety alerts, recalls, studies and legal news all in one place, they can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
The Mirena IUD is a levonorgestrel-based contraceptive approved by the FDA in 2000. The resource center previously added warnings from health experts such as the FDA that patients can suffer reproductive organ tearing during device implantation**.
DrugNews has also added information showing a federal judicial panel is deciding whether to consolidate a growing number of claims alleging the device caused vision problems due to a condition called pseudotumor cerebri, or PTC, into a special Mirena court***.
Now, the resource center has learned of a study from Finland of more than 93,000 women that found a higher rate of breast cancer among those using levonorgestrel-based contraceptives*.
Anyone who suffered uterus perforation, vision loss or PTC while using a Mirena IUD is urged to visit DrugNews.net for more information or speak with a lawyer about their legal options. DrugNews only recommends lawyers who are already handling Mirena lawsuits.
For more information on the research, side effects and litigation news related to Mirena or other birth control devices, or to speak with a lawyer, visit http://www.DrugNews.net.
*Soino, T. Obstetrics & Gynecology, August 2014; http://journals.lww.com/greenjournal/Citation/2014/08000/Cancer_Risk_in_Women_Using_the.13.aspx
**FDA, July 2008; http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121936.htm
***JPML, 6/16/14, MDL 2559, (In RE: Mirena IUD Levonorgestrel-Related Products Liability Litigation, Pending No. 63); jpml.uscourts.gov/sites/jpml/files/Hearing_Order-7-31-14.pdf